Taiho to acquire Merck & Co's Japanese R&D centre
This article was originally published in Scrip
Executive Summary
Merck & Co's wholly owned Japanese subsidiary, Banyu, has agreed to sell its main R&D facility to Taiho Pharmaceutical, a mid-sized Japanese company specialising in oncology.